Kevin G. Billingsley, MD

Kevin G. Billingsley, MD, MBA, is a surgical oncologist who specializes in the surgical treatment of gastrointestinal cancers. He treats tumors of the liver, pancreas, gall bladder, and bile ducts, including cholangiocarcinoma. Dr. Billingsley also has expertise in metastatic tumors in the liver.

Dr. Billingsley says he considers caring for cancer patients a privilege and a calling. He works closely with medical oncologists, gastroenterologists, interventional radiologists, and other specialists to coordinate care for his patients. He most values the relationships he develops with patients and their families through the course of the cancer care journey. 

Dr. Billingsley serves as the chief medical officer for the Yale Cancer Center and Smilow Cancer Hospital and Care Centers, where he oversees quality and patient safety initiatives across the cancer care enterprise. He leads the improvement of multidisciplinary team structures, assists with facilities and space planning, and works closely with Yale New Haven Health System’s clinical leaders.

Dr. Billingsley’s research interests include gastrointestinal cancers with a particular emphasis on developing new multidisciplinary treatment strategies for metastatic colorectal cancer, and improving clinical outcomes following complex liver and pancreas operations. In his leadership role, his interests include the development of integrated academic health care systems, patient communication, and strategies to support clinician resilience.